Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

News

 

CMA price tag looks embarrassingly high

Potentially embarrassing details of the acquisition of CMA-Medina, the largest independent lab group in Belgium by French player Biogroup have emerged. Articles in the Belgian business press suggest massive gross margins and speculation that CMA sold for €1bn.
September 24, 2020

Diversification helps Grupo 5 grow despite COVID

Grupo 5 has carved out an unusual but successful niche for itself in Spain, balancing a mix of healthcare services (predominantly mental health and treatment for patients with brain injuries) with social emergency care for the homeless, children, and people with disability. CEO Guillermo Bell tells HBI it has proved to be a robust combination during the COVID crisis.
September 24, 2020

How Covid opens up new B2B and B2C testing markets

The lab sector could be "uberised" by an app which currently enables individuals to see where, and when they can get a Covid test as part of government and corporate schemes. The aim is to create a consumer solution which will enable individuals to select from a very wide range of tests on price and proximity.
September 24, 2020

Employee testing drives 30%+ organic growth for labs through summer

COVID-19 testing for businesses, the sports industry and governments has cancelled-out and countered most falls in routine testing for the pan-European lab groups. Synlab says it signed 3,000 back-to-work testing contracts and saw 32% y-o-y organic revenue growth in June while Eurofins has 1,200 signed or in discussion. HBI examines the impact of the pandemic so far and what's next.
September 17, 2020

Mehilainen ‘spinning off digital arm’ as Pihlajalinna deadline looms

Finnish healthcare group Mehilainen is spinning off its digital consultancy business into a separate company which would make it easier to sell off in future, a senior banker tells HBI. An analyst adds that raising cash this way makes sense considering what has happened since it offered to buy competitor Pihlajalinna.
September 17, 2020

Apollo Q1 results highlight scope of COVID impact in India

The effect of the COVID crisis was evident in Indian hospital chain Apollo's Q1 results, announced on Monday. It reported a consolidated net loss of Rs 226 crore ($31m) for the quarter ending June 30, but there was a silver lining in the growth of it's pharmacy business.
September 17, 2020

Insurers record massive savings from deploying telehealth

Traditional hospital business models stand to be massively disrupted as payors adopt front-end telehealth. Early adopters insurers Cigna and Aetna are seeing high patient satisfaction and huge cost savings from the deployment of telehealth in EMEA and emerging markets. Cigna is starting to grade quality at operators outside of the USA, according to the latest HBI-365 panel discussion. Go to HBI-365.com to find out more.
September 17, 2020

Mediclinic: stake in Swiss procurement disruptor “does not impact Sana agreement”

Switzerland's largest private hospital group Hirslanden's investment in a self-proclaimed 'disruptive' procurement outfit does not affect its cooperation with the procurement hub of German hospital Sana, parent company Mediclinic tells HBI. But the group has yet to reveal what it has gotten out of the cooperation with Sana. 
September 17, 2020
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us